Modi Ventures

Making waves from Wall Street to brainwaves! Elemind’s CEO, Meredith Perry, hosted by the NYSE and Cheddar anchor, Dave Briggs, signaling big things for sleep and neurotech. Experience brainwave-powered rest. Pre-order your Elemind today. #Elemind #NYSE #BrainwaveTech

So honored to share that General Proximity was one of the 23 awardees (out of 1700+ applicants!) for the Advanced Research Projects Agency for Health (ARPA-H) #SprintForWomensHealth! This $3M grant will support our team as we advance next-gen proximity therapeutics for high value undruggable targets in the women’s cancer space towards the clinic. Dedicating this work to my incredible mother, Suzanne Cognetta. I began working on cancer therapeutics after she was diagnosed with breast cancer for the second time and I realized that despite being in one of the best chemical biology labs in the world, I was powerless to help her. Hopefully our work here will be a big step towards changing that for all the women and mothers in the world.

So exciting to see Elemind Technologies, Inc., Modi Ventures's portfolio company, being featured in The Wall Street Journal 👇

Congrats Rockwell Shah and Ozlo Sleep team! Glad to be on this incredible journey with you!

The 2024 FIRST Global (IFCA) Challenge in Athens was nothing short of magical. ✨ Standing in the Panathenaic Stadium, where the first modern Olympic games took place, I couldn’t help but feel the immense weight of history blending with the boundless potential of the future. This wasn’t just another event—it was a global movement. 🌍 More than 190 countries came together, not to compete in sports, but to race toward a better, more sustainable world through innovation and technology. These young minds didn’t just build robots; they built bridges—across cultures, languages, and continents. Watching them work side by side, we saw firsthand how technology can unite us, how creativity and collaboration can transcend borders, and how hope for a brighter future can inspire action. The energy was beyond words. From the electrifying Black Eyed Peas performance to the inspiring moments of teamwork and perseverance, it was a celebration of what we can achieve when we come together with a shared purpose. I’ve never been prouder to be a part of something so powerful. These young innovators reminded us all of what’s possible when we dream big, work together, and believe in a better future. Thank you to the small and mighty team and the continued commitment of our numerous supporters! Kathryn Williams, Steven Valentine, Laura London, Ceci Neumann, Kent Hughes, Matthew Stalford, Jeff Colangelo, Alvaro Argueta, Khadijah B, Stephanie A. Slezycki, Mike Walker, Vince Wilczynski, Anthony Bolzan, Chryssoula Koniakou, Michalis Marinakis, Anastasios Kollias, PhD, Giannis Vergidis, Konstantinos Kyranakis, Sallie Olmsted, APR, Mindy Skripsky, Steve Krawic, CEM, Greg Needel, David Yanoshak, Christie Valdez, Steve Fine, Emily Sechrist, Kelly Levin, Andy Jarvis, Gonzalo Ortiz, Bill Karnazes, Sahirzeeshan (Sahir) Ali! Lam Research, Bezos Earth Fund, Tullman Family Office, Hellenic Ministry of Digital Governance, MellonLab, Bezos Family, DEKA Research & Development, Pershing Square Philanthropies, FedEx, The Coca-Cola Company, Nefro Health, Aureum Space, Viohalco, Modi Ventures, ERT S.A. HELLENIC BROADCASTING CORPORATION, OTE Group of Companies (HTO), more.com, Municipality of Piraeus. #FIRSTGlobalChallenge #FIRSTGlobal

Huge congrats to Sarah Hein and March Biosciences on this milestone! Excited to have Modi Ventures join you on this journey to bring new, life-saving therapies for patients battling T Cell Lymphomas.  Especially proud to see this out of #Houston! 

Fantastic to see one of Modi Ventures portcos, Lapsi Health, featured in TechCrunch! Big launch tomorrow 🚀 Jhonatan Bringas Dimitriades, MD

Please join Jhonatan Bringas Dimitriades, MD and Lapsi Health team on Oct 1st as they unveil their game-changing first product. You can sign up for this live streaming event below.

We are thrilled to see that Modi Ventures portfolio company Generate:Biomedicines is collaborating with Novartis to design and develop protein therapeutics across multiple disease areas through generative AI. This collaboration is potentially valued at more than $1 billion with $65 million in total upfront. Congratulations to Michael Nally and his team! 

We have important news to announce today! Tiny Health has appointed Dr Elisa Song as our Chief Medical Officer and Dr Taylor Sittler as our Board Director. When I first met Elisa Song, MD, it was like a meeting of souls, minds and a singular vision. Dr Song has been educating both parents and practitioners alike about the importance of pediatric gut health for decades and we just got started at Tiny Health. Together, we collaborated and created a professional-version of what we think is the best gut health test in the market: the PRO. When 1 in 2 kids are impacted by at least 1 chronic condition, we believe that there's no great mission than to tackle the root cause of these conditions by modulating the gut microbiome in early life. In the near future, we will be working towards our mutual vision of making pediatric gut health testing the standard of care for all infants, babies and kids. When I first met Taylor Sittler (shoutout to Julia Lipton), I think we spent 2 straight hours speaking about the parallels and learnings from his time at Color and how we may apply them to our clinical growth at Tiny Health. Taylor quickly became a true believer and an angel investor, right before our Series A. A few months later, he even became an avid customer when his son was born. Taylor has been a core part of our R&D and clinical team, and he brings both physician and founder/operator experience to support me on the board, alongside our incredible VC partners Sara Eshelman and Laura González-Estéfani. I am so grateful to have the support of two esteemed physicians and leaders in their field. Our meaningful work together has just begun! This week, for the 2nd year in a row, we'll be speaking at the A4M pediatric symposium in LA, which is chaired by Dr Elisa Song. Our Medical Director Taylor Soderborg, MD, PhD will present our research and knowledge on gut-immune development in the first 1,000 days and strategies to restore missing Bifidobacterium in our children. We have a lot more exciting news in store in the coming quarters - we hope that you'll follow along our journey and support us in changing the statistics in our chronic condition crisis, for both children and adults alike.